Effects of Task-Oriented Training With and Without Rhythmic Auditory Stimulation in Post-Stroke Patients

NCT07724730 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2026-07-24

No results posted yet for this study

Summary

Stroke is one of the leading causes of long-term disability worldwide. Among survivors, limitations in lower limb motor function, balance, and proprioception significantly affect their independence and quality of life. There is a growing need for targeted rehabilitation strategies for stroke survivors, who often experience lower limb impairments that limit independence during a highly active stage of life. Task-oriented training (TOT) helps patients practice real-life movements, while rhythmic auditory stimulation (RAS), such as metronome beats, can guide and improve their timing and coordination.

Conditions

Interventions

OTHER

Task-Oriented Training + Rhythmic Auditory Stimulation

* 30-minute TOT session + RAS (60-110 BPM progression) * Functional gait tasks, obstacle walking, stair climbing, balance tasks * 5 days/week for 8 weeks * Plus 30-minute baseline physiotherapy

OTHER

Task-Oriented Training Only

* Same TOT structure without rhythmic cues * Functional lower limb tasks, balance training, gait practice * 5 days/week for 8 weeks * Plus 30-minute baseline physiotherapy

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Aiza Yousaf, MS-OMPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2026-07-30
Completion
2026-08-05

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07724730 on ClinicalTrials.gov